1. Home
  2. SKY vs ADPT Comparison

SKY vs ADPT Comparison

Compare SKY & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skyline Champion Corporation

SKY

Skyline Champion Corporation

N/A

Current Price

$90.36

Market Cap

4.9B

ML Signal

N/A

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$25.31

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKY
ADPT
Founded
2010
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.1B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
SKY
ADPT
Price
$90.36
$25.31
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$98.50
$17.78
AVG Volume (30 Days)
697.5K
2.3M
Earning Date
05-26-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
7.02
63.89
EPS
0.89
N/A
Revenue
$2,663,639,000.00
$276,976,000.00
Revenue This Year
$7.79
$3.98
Revenue Next Year
$3.10
$22.72
P/E Ratio
$101.16
N/A
Revenue Growth
7.26
54.77
52 Week Low
$63.69
$12.00
52 Week High
$99.17
$26.87

Technical Indicators

Market Signals
Indicator
SKY
ADPT
Relative Strength Index (RSI) 53.85 59.47
Support Level $89.31 $23.92
Resistance Level $98.08 $26.16
Average True Range (ATR) 2.33 1.01
MACD -0.55 -0.05
Stochastic Oscillator 18.20 62.71

Price Performance

Historical Comparison
SKY
ADPT

About SKY Skyline Champion Corporation

Champion Homes Inc is a factory-built housing company in North America. The company is well positioned with an portfolio of manufactured and modular homes, ADUs, park-models and modular buildings for the single-family, multi-family, and other hospitality sectors. In addition to its core home building business, the company provides construction services to install and set-up factory-built homes, operates a factory-direct retail business with 72 retail locations across the United States, and operates Star Fleet Trucking, providing transportation services to the manufactured housing and other industries from several dispatch locations across the United States.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: